Oscotec Inc. (KOSDAQ:039200)
South Korea · Delayed Price · Currency is KRW 31,250
+50 (0.16%)
Aug 8, 2025, 3:30 PM KST
Oscotec Revenue
Oscotec had revenue of 1.94B KRW in the quarter ending March 31, 2025, with 82.34% growth. This brings the company's revenue in the last twelve months to 34.88B, up 617.11% year-over-year. In the year 2024, Oscotec had annual revenue of 34.01B with 586.89% growth.
Revenue (ttm)
34.88B
Revenue Growth
+617.11%
P/S Ratio
34.22
Revenue / Employee
683.96M
Employees
51
Market Cap
1,193.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.01B | 29.06B | 586.89% |
| Dec 31, 2023 | 4.95B | -111.45M | -2.20% |
| Dec 31, 2022 | 5.06B | 1.16B | 29.71% |
| Dec 31, 2021 | 3.90B | -39.57B | -91.02% |
| Dec 31, 2020 | 43.47B | 39.10B | 895.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| Peptron | 4.30B |
| PharmaResearch | 392.31B |
| HLB Co., Ltd. | 74.64B |